Loading organizations...
Loading organizations...
Pioneering third generation biological drugs for cancer and autoimmune diso
KAHR medical has raised $62.0M across 3 funding rounds.
KAHR medical has raised $62.0M in total across 3 funding rounds.
KAHR medical has raised $62.0M in total across 3 funding rounds.
KAHR medical's investors include Ted Fjällman, Cancer Focus Fund, Oriella, Peregrine Ventures, SPRIM Global Investments, Flerie Invest, Hadasit Bio-Holdings, Mirae Asset Venture Investment, Pavilion Capital, Korea Investment Partners, DSC Investment.
KAHR medical has raised $62.0M across 3 funding rounds. Most recently, it raised $32.0M Debt / Other Equity in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 8, 2026 | $32.0M Debt / Other Equity | Ted Fjällman, Cancer Focus Fund, Oriella, Peregrine Ventures | SPRIM Global Investments |
| Feb 25, 2020 | $18.0M Other Equity | Flerie Invest, Hadasit Bio-Holdings, Mirae Asset Venture Investment, Oriella, Pavilion Capital | |
| Dec 15, 2015 | $12.0M Series B | Korea Investment Partners, DSC Investment, Flerie Invest, Mirae Asset Venture Investment |